Thursday, January 29, 2015

Gardasil Launch

ANGELMAR Reinhard, KIM Juliana, SCHROEDER Michael
©2015 INSEAD Case Study
Get the case from INSEAD Case Publishing

Merck & Co is preparing the launch of Gardasil, the first human papillomavirus (HPV) vaccine. Because knowledge of HPV is poor among potential vaccinees and other stakeholders (parents, physicians, third-party payers), and there is no habit of vaccinating adolescents, Merck needs to develop pre-launch programmes. Which potential vaccinees to target and how to position Gardasil - to prevent HPV, genital warts, cervical cancer, or both genital warts and cervical cancer - are other important decisions.